These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28635890)

  • 1. [Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication].
    Konorev MR; Andronova TM; Matveenko ME
    Ter Arkh; 2016; 88(12):140-148. PubMed ID: 28635890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.
    Fang HR; Zhang GQ; Cheng JY; Li ZY
    Eur J Pediatr; 2019 Jan; 178(1):7-16. PubMed ID: 30446816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy.
    Wang ZH; Gao QY; Fang JY
    J Clin Gastroenterol; 2013 Jan; 47(1):25-32. PubMed ID: 23090045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
    McNicholl AG; Molina-Infante J; Lucendo AJ; Calleja JL; Pérez-Aisa Á; Modolell I; Aldeguer X; Calafat M; Comino L; Ramas M; Callejo Á; Badiola C; Serra J; Gisbert JP
    Helicobacter; 2018 Oct; 23(5):e12529. PubMed ID: 30141228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.
    Feng JR; Wang F; Qiu X; McFarland LV; Chen PF; Zhou R; Liu J; Zhao Q; Li J
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1199-1208. PubMed ID: 28681177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of compound
    Ji W; Chen WQ; Tian X
    BMJ Open; 2018 Oct; 8(10):e023131. PubMed ID: 30373781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
    Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
    Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
    Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
    PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of
    Si XB; Lan Y; Qiao L
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):752-759. PubMed ID: 29036957
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children.
    Goldman CG; Barrado DA; Balcarce N; Rua EC; Oshiro M; Calcagno ML; Janjetic M; Fuda J; Weill R; Salgueiro MJ; Valencia ME; Zubillaga MB; Boccio JR
    Nutrition; 2006 Oct; 22(10):984-8. PubMed ID: 16978844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy.
    Zhu XY; Liu F
    J Dig Dis; 2017 Apr; 18(4):195-202. PubMed ID: 28294543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are probiotics useful for therapy of Helicobacter pylori diseases?
    Eslami M; Yousefi B; Kokhaei P; Jazayeri Moghadas A; Sadighi Moghadam B; Arabkari V; Niazi Z
    Comp Immunol Microbiol Infect Dis; 2019 Jun; 64():99-108. PubMed ID: 31174707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis.
    Wang F; Feng J; Chen P; Liu X; Ma M; Zhou R; Chang Y; Liu J; Li J; Zhao Q
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):466-475. PubMed ID: 28552432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
    Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Zhang MM; Qian W; Qin YY; He J; Zhou YH
    World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy].
    Konorev MR
    Ter Arkh; 2012; 84(12):66-70. PubMed ID: 23479993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Zou J; Dong J; Yu X
    Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.
    Wilhelm SM; Johnson JL; Kale-Pradhan PB
    Ann Pharmacother; 2011 Jul; 45(7-8):960-6. PubMed ID: 21693698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.